Site of the inhibiting action of diphenylhydantoin on the release of corticotrophin in epileptic patients.
D015065:17-Hydroxycorticosteroids / Q000097:blood / Q000652:urine; D000311:Adrenal Glands / Q000187:drug effects; D000324:Adrenocorticotropic Hormone / Q000378:metabolism*; D004830:Epilepsy, Tonic-Clonic / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects*; D008297:Male; D008797:Metyrapone; D010672:Phenytoin / Q000494:pharmacology*; D010902:Pituitary Gland / Q000187:drug effects; D014667:Vasopressins
D015065:17-Hydroxycorticosteroids; D014667:Vasopressins; D010672:Phenytoin; D000324:Adrenocorticotropic Hormone; D008797:Metyrapone